USFDA concludes inspection at Biocon's API manufacturing facility in Telangana

17 Dec 2018 Evaluate

US Food and Drug Administration (USFDA) has conducted a GMP inspection at Biocon's API manufacturing facility at Telangana from December 12 to 14, 2018. The inspection concluded without any observations and no Form 483 was issued. The successful inspection of this site reflects company's strong commitment to quality and cGMP compliance.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×